Related Experiment Video
Updated: May 30, 2026

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
Published on: October 4, 2017
Cysteamine toxicity in patients with cystinosis
Martine T P Besouw1, Richard Bowker, Jean-Paul Dutertre
1Department of Pediatric Nephrology, Laboratory of Pediatrics, University Hospitals Leuven, Leuven, Belgium.
Cysteamine treatment for cystinosis can cause new adverse effects like skin and vascular lesions. Reducing the cysteamine dose often improves these symptoms, indicating a potential link.
Area of Science:
- Pharmacology
- Dermatology
- Neurology
Background:
- Cysteamine is a treatment for cystinosis.
- The long-term safety profile of cysteamine requires ongoing evaluation.
Related Concept Videos
Urinary Tract Calculi I: Introduction
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Chronic Kidney Disease III: Interprofessional Care

